Zachary F Meisel1, Nicoleta Lupulescu-Mann2, Christina J Charlesworth2, Hyunjee Kim2, Benjamin C Sun3. 1. Center for Emergency Care Policy Research, Department of Emergency Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Leonard Davis Institute of Health Economics, and the Penn Injury Science Center, University of Pennsylvania, Philadelphia, PA; Center for Health Economics for Treatment Interventions of Substance Use Disorder, HIV, HCV. Electronic address: zfm@wharton.upenn.edu. 2. Center for Health Systems Effectiveness, Oregon Health & Science University, Portland, OR. 3. Center for Emergency Care Policy Research, Department of Emergency Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Leonard Davis Institute of Health Economics, and the Penn Injury Science Center, University of Pennsylvania, Philadelphia, PA; Center for Health Systems Effectiveness, Oregon Health & Science University, Portland, OR.
Abstract
STUDY OBJECTIVE: We describe the overall risk and factors associated with transitioning to persistent opioid or high-risk use after an initial emergency department (ED) opioid prescription. METHODS: A retrospective cohort study of Washington Medicaid beneficiaries was performed with linked Medicaid and prescription drug monitoring program files. We identified adults who had no record of opioid prescriptions in the previous 12 months, and who filled a new opioid prescription within 1 day of an ED discharge in 2014. We assessed the risk of persistent opioid use or high-risk prescription fills within 12 months after the index visit. Logistic regression was used to assess the association between pertinent variables and conversion to persistent or high-risk use. RESULTS: Among 202,807 index ED visits, 23,381 resulted in a new opioid prescription. Of these, 13.7% led to persistent or high-risk opioid prescription fills within 12 months compared with 3.2% for patients who received no opioids at the index visit. Factors associated with increased likelihood of persistent opioid or high-risk prescription fills included a history of skeletal or connective-tissue disorder; neck, back, or dental pain; and a history of prescribed benzodiazepines. The highest conversion rates (37.3%) were observed among visits in which greater than or equal to 350 morphine milligram equivalents were prescribed. Conversion rates remained greater than 10% even among visits resulting in lower-dose opioid prescriptions. CONCLUSION: Medicaid recipients are at moderate risk for conversion to persistent or high-risk opioid use after a new ED prescription. Longer or higher-dose prescriptions are associated with increased risk for conversion; however, even visits that lead to guideline-concordant prescriptions bear some risk for long-term or high-risk use.
STUDY OBJECTIVE: We describe the overall risk and factors associated with transitioning to persistent opioid or high-risk use after an initial emergency department (ED) opioid prescription. METHODS: A retrospective cohort study of Washington Medicaid beneficiaries was performed with linked Medicaid and prescription drug monitoring program files. We identified adults who had no record of opioid prescriptions in the previous 12 months, and who filled a new opioid prescription within 1 day of an ED discharge in 2014. We assessed the risk of persistent opioid use or high-risk prescription fills within 12 months after the index visit. Logistic regression was used to assess the association between pertinent variables and conversion to persistent or high-risk use. RESULTS: Among 202,807 index ED visits, 23,381 resulted in a new opioid prescription. Of these, 13.7% led to persistent or high-risk opioid prescription fills within 12 months compared with 3.2% for patients who received no opioids at the index visit. Factors associated with increased likelihood of persistent opioid or high-risk prescription fills included a history of skeletal or connective-tissue disorder; neck, back, or dental pain; and a history of prescribed benzodiazepines. The highest conversion rates (37.3%) were observed among visits in which greater than or equal to 350 morphine milligram equivalents were prescribed. Conversion rates remained greater than 10% even among visits resulting in lower-dose opioid prescriptions. CONCLUSION: Medicaid recipients are at moderate risk for conversion to persistent or high-risk opioid use after a new ED prescription. Longer or higher-dose prescriptions are associated with increased risk for conversion; however, even visits that lead to guideline-concordant prescriptions bear some risk for long-term or high-risk use.
Authors: Stephen V Cantrill; Michael D Brown; Russell J Carlisle; Kathleen A Delaney; Daniel P Hays; Lewis S Nelson; Robert E O'Connor; Annmarie Papa; Karl A Sporer; Knox H Todd; Rhonda R Whitson Journal: Ann Emerg Med Date: 2012-10 Impact factor: 5.721
Authors: Daniel Polsky; Michael Richards; Simon Basseyn; Douglas Wissoker; Genevieve M Kenney; Stephen Zuckerman; Karin V Rhodes Journal: N Engl J Med Date: 2015-01-21 Impact factor: 91.245
Authors: Shaina Sekhri; Nonie S Arora; Hannah Cottrell; Timothy Baerg; Anthony Duncan; Hsou Mei Hu; Michael J Englesbe; Chad Brummett; Jennifer F Waljee Journal: Ann Surg Date: 2018-08 Impact factor: 12.969
Authors: Robert J Smith; Karin Rhodes; Breah Paciotti; Sheila Kelly; Jeanmarie Perrone; Zachary F Meisel Journal: Ann Emerg Med Date: 2015-04-09 Impact factor: 5.721
Authors: Jennifer Brennan Braden; Joan Russo; Ming-Yu Fan; Mark J Edlund; Bradley C Martin; Andrea DeVries; Mark D Sullivan Journal: Arch Intern Med Date: 2010-09-13
Authors: Benjamin C Sun; Christina J Charlesworth; Nicoleta Lupulescu-Mann; Jenny I Young; Hyunjee Kim; Daniel M Hartung; Richard A Deyo; K John McConnell Journal: Ann Emerg Med Date: 2017-12-13 Impact factor: 5.721
Authors: Iraklis E Tseregounis; Daniel J Tancredi; Susan L Stewart; Aaron B Shev; Andrew Crawford; James J Gasper; Garen Wintemute; Brandon D L Marshall; Magdalena Cerdá; Stephen G Henry Journal: Med Care Date: 2021-12-01 Impact factor: 2.983
Authors: Stephen G Henry; Susan L Stewart; Eryn Murphy; Iraklis Erik Tseregounis; Andrew J Crawford; Aaron B Shev; James J Gasper; Daniel J Tancredi; Magdalena Cerdá; Brandon D L Marshall; Garen J Wintemute Journal: J Gen Intern Med Date: 2021-03-19 Impact factor: 5.128
Authors: Jorge Enrique Machado-Alba; Laura Sofía Serna-Echeverri; Luis Fernando Valladales-Restrepo; Manuel Enrique Machado-Duque; Andrés Gaviria-Mendoza Journal: Pain Res Manag Date: 2020-11-20 Impact factor: 3.037
Authors: Andrew C Meltzer; Allan B Wolfson; Patrick Mufarrij; Cora MacPherson; Nataly Montano; Ziya Kirkali; Pamela Katzen Burrows; Stephen V Jackman Journal: J Endourol Date: 2021-01-21 Impact factor: 2.619